Found: 129
Select item for more details and to access through your institution.
Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Polatuzumab vedotin, venetoclax, and an anti‐CD20 monoclonal antibody in relapsed/refractory B‐cell non‐Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1281, doi. 10.1002/ajh.27341
- By:
- Publication type:
- Article
Marginal zone lymphoma: 2023 update on diagnosis and management.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1645, doi. 10.1002/ajh.27058
- By:
- Publication type:
- Article
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 599, doi. 10.1002/ajh.26149
- By:
- Publication type:
- Article
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression‐free survival and early treatment failure after frontline immunochemotherapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1503, doi. 10.1002/ajh.25973
- By:
- Publication type:
- Article
Dasatinib therapy can result in significant pulmonary toxicity.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. E224, doi. 10.1002/ajh.24194
- By:
- Publication type:
- Article
Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad550
- By:
- Publication type:
- Article
Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Distress and unmet needs during treatment and quality of life in early cancer survivorship: A longitudinal study of haematological cancer patients.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 5, p. 423, doi. 10.1111/ejh.12941
- By:
- Publication type:
- Article
[18F]Fluorodeoxyglucose Positron Emission Tomography Scanning for Staging, Response Assessment, and Disease Surveillance in Patients with Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 3, p. 159
- By:
- Publication type:
- Article
Primary Non-Hodgkin's Lymphoma of the Breast: Retrospective Analysis of Prognosis and Patterns of Failure in Two Australian Centers.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 4, p. 337
- By:
- Publication type:
- Article
Fludarabine Combination Therapy Is Highly Effective in First-Line and Salvage Treatment of Patients with Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 2, p. 136
- By:
- Publication type:
- Article
Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail.
- Published in:
- BMC Biotechnology, 2008, v. 8, p. 1, doi. 10.1186/1472-6750-8-6
- By:
- Publication type:
- Article
Hardrock Mining and the Environment: Issues of Federal Enforcement and Liability.
- Published in:
- Ecology Law Quarterly, 2004, v. 31, n. 4, p. 795
- By:
- Publication type:
- Article
Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 11, p. 1, doi. 10.1002/cti2.1351
- By:
- Publication type:
- Article
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia.
- Published in:
- Emerging Infectious Diseases, 2010, v. 16, n. 7, p. 1068, doi. 10.3201/eid1607.091691
- By:
- Publication type:
- Article
Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment.
- Published in:
- Journal of Medical Internet Research, 2017, v. 19, n. 12, p. 1, doi. 10.2196/mhealth.8349
- By:
- Publication type:
- Article
Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency.
- Published in:
- Acta Haematologica, 2013, v. 130, n. 4, p. 254, doi. 10.1159/000351048
- By:
- Publication type:
- Article
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 415, doi. 10.3390/ijms18020415
- By:
- Publication type:
- Article
A case of delayed methotrexate clearance following administration of a complementary medication containing chlorophyll.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 3, p. 225, doi. 10.1177/1078155213492553
- By:
- Publication type:
- Article
Induction of hypomagnesemia during amsacrine treatment.
- Published in:
- American Journal of Hematology, 1993, v. 42, n. 3, p. 262, doi. 10.1002/ajh.2830420305
- By:
- Publication type:
- Article
Risk Factors for and Outcomes of Follicular Lymphoma Histological Transformation at First Progression in the GALLIUM Study.
- Published in:
- 2023
- By:
- Publication type:
- journal article
CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01750-X
- By:
- Publication type:
- Article
Poster: CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01389-6
- By:
- Publication type:
- Article
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S303, doi. 10.1016/j.clml.2017.07.098
- By:
- Publication type:
- Article
Venetoclax Plus Rituximab can Achieve Durable Treatment-Free Remission in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S50, doi. 10.1016/j.clml.2016.07.073
- By:
- Publication type:
- Article
Cross-Study Multivariable Analysis of the Impact of Adding Rituximab to Venetoclax on the Depth and Durability of Response in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S51, doi. 10.1016/j.clml.2016.07.074
- By:
- Publication type:
- Article
The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A Risk-Adapted Protocol for Delayed Administration of Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 42, doi. 10.1016/j.clml.2012.09.017
- By:
- Publication type:
- Article
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- editorial
Update on the management of relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01001-1
- By:
- Publication type:
- Article
Update on the management of relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01001-1
- By:
- Publication type:
- Article
Correction: Zanubrutinib: past, present, and future.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Zanubrutinib: past, present, and future.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
- By:
- Publication type:
- Article
Zanubrutinib: past, present, and future.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00902-x
- By:
- Publication type:
- Article
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01469-7
- By:
- Publication type:
- Article
Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01295-3
- By:
- Publication type:
- Article
Central Nervous System Prophylaxis in Non-Hodgkin Lymphoma: Who, What, and When?
- Published in:
- Current Oncology Reports, 2015, v. 17, n. 6, p. 1, doi. 10.1007/s11912-015-0450-4
- By:
- Publication type:
- Article
Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (Hi DAC) based induction chemotherapy.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 6, p. 861, doi. 10.1111/bjh.12178
- By:
- Publication type:
- Article
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 39, doi. 10.1111/j.1365-2141.2010.08162.x
- By:
- Publication type:
- Article
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 2, p. 244, doi. 10.1111/j.1365-2141.2010.08082.x
- By:
- Publication type:
- Article
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 1, p. 83, doi. 10.1111/j.1365-2141.2009.07835.x
- By:
- Publication type:
- Article
Fludarabine combinations for patients with advanced marginal zone lymphomas – best treatment option or too toxic?
- Published in:
- 2009
- By:
- Publication type:
- Letter
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 253, doi. 10.1111/j.1365-2141.2008.07338.x
- By:
- Publication type:
- Article
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 1, p. 3, doi. 10.1111/j.1365-2141.2005.05789.x
- By:
- Publication type:
- Article
Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 1, p. 87, doi. 10.1111/j.1365-2141.2005.05570.x
- By:
- Publication type:
- Article
Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the‘cutaneous variant’.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 2, p. 173, doi. 10.1111/j.1365-2141.2004.05177.x
- By:
- Publication type:
- Article